Amyotrophic lateral sclerosis: an update on treatments from clinical trials.
作者信息
Wynford-Thomas Ray, Robertson Neil P
机构信息
Department of Neurology, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN, UK.
Department of Neurology, Division of Psychological Medicine and Clinical Neuroscience, Cardiff University, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN, UK.
出版信息
J Neurol. 2023 Feb;270(2):1187-1189. doi: 10.1007/s00415-022-11553-6. Epub 2023 Jan 16.
Abstract
摘要
相似文献
1
Amyotrophic lateral sclerosis: an update on treatments from clinical trials.肌萎缩侧索硬化症：临床试验治疗进展
J Neurol. 2023 Feb;270(2):1187-1189. doi: 10.1007/s00415-022-11553-6. Epub 2023 Jan 16.
2
Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease.重组人胰岛素样生长因子I（rhIGF-I）用于治疗肌萎缩侧索硬化症/运动神经元病。
Cochrane Database Syst Rev. 2002(3):CD002064. doi: 10.1002/14651858.CD002064.
3
Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron disease.肌萎缩侧索硬化症/运动神经元病的抗氧化治疗
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD002829. doi: 10.1002/14651858.CD002829.pub4.
4
A systematic review of antioxidant treatment for amyotrophic lateral sclerosis/motor neuron disease.肌萎缩侧索硬化症/运动神经元病抗氧化治疗的系统评价
Amyotroph Lateral Scler. 2008 Aug;9(4):195-211. doi: 10.1080/17482960801900032.
5
Amyotrophic lateral sclerosis: update for family physicians.肌萎缩侧索硬化症：给家庭医生的最新资讯
Can Fam Physician. 2006 Dec;52(12):1563-9.
6
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).利鲁唑用于治疗肌萎缩侧索硬化症（ALS）/运动神经元病（MND）。
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD001447. doi: 10.1002/14651858.CD001447.pub3.
7
Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective.肌萎缩侧索硬化症的临床试验：系统评价与展望
Brain Commun. 2021 Oct 23;3(4):fcab242. doi: 10.1093/braincomms/fcab242. eCollection 2021.
8
Amyotrophic lateral sclerosis: current practice and future treatments.肌萎缩侧索硬化症：当前实践与未来治疗。
Curr Opin Neurol. 2010 Oct;23(5):524-9. doi: 10.1097/WCO.0b013e32833c7ac2.
9
Recombinant human insulin-like growth factor I (rhIGF-I) for amyotrophic lateral sclerosis/motor neuron disease.重组人胰岛素样生长因子I（rhIGF-I）用于治疗肌萎缩侧索硬化症/运动神经元病。
Cochrane Database Syst Rev. 2007 Oct 17(4):CD002064. doi: 10.1002/14651858.CD002064.pub2.
10
Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron disease.肌萎缩侧索硬化症/运动神经元病的抗氧化治疗
Cochrane Database Syst Rev. 2005 Jan 25(1):CD002829. doi: 10.1002/14651858.CD002829.pub3.
引用本文的文献
1
Artificial intelligence models using F-wave responses predict amyotrophic lateral sclerosis.使用F波反应的人工智能模型可预测肌萎缩侧索硬化症。
Brain. 2025 Jul 7;148(7):2320-2330. doi: 10.1093/brain/awaf014.
2
Case report: Flail leg syndrome in familial amyotrophic lateral sclerosis with L144S mutation.病例报告：伴有L144S突变的家族性肌萎缩侧索硬化中的连枷腿综合征
Front Neurol. 2023 Mar 22;14:1138668. doi: 10.3389/fneur.2023.1138668. eCollection 2023.
Zotero 插件